Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens.
Clayton SJ, May FE, Westley BR. Clayton SJ, et al. Among authors: may fe. Mol Cell Endocrinol. 1997 Apr 4;128(1-2):57-68. doi: 10.1016/s0303-7207(96)04016-6. Mol Cell Endocrinol. 1997. PMID: 9140076
Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58.
Chadwick MP, Westley BR, May FE. Chadwick MP, et al. Among authors: may fe. Biochem J. 1997 Oct 1;327 ( Pt 1)(Pt 1):117-23. doi: 10.1042/bj3270117. Biochem J. 1997. PMID: 9355742 Free PMC article.
The trefoil factor interacting protein TFIZ1 binds the trefoil protein TFF1 preferentially in normal gastric mucosal cells but the co-expression of these proteins is deregulated in gastric cancer.
May FE, Griffin SM, Westley BR. May FE, et al. Int J Biochem Cell Biol. 2009 Mar;41(3):632-40. doi: 10.1016/j.biocel.2008.07.015. Epub 2008 Aug 3. Int J Biochem Cell Biol. 2009. PMID: 18722547 Free PMC article.
The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells.
Prest SJ, May FE, Westley BR. Prest SJ, et al. Among authors: may fe. FASEB J. 2002 Apr;16(6):592-4. doi: 10.1096/fj.01-0498fje. FASEB J. 2002. PMID: 11919164
Expression and motogenic activity of TFF2 in human breast cancer cells.
May FE, Semple JI, Prest SJ, Westley BR. May FE, et al. Peptides. 2004 May;25(5):865-72. doi: 10.1016/j.peptides.2003.12.024. Peptides. 2004. PMID: 15177883
Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC, May FE. Luey BC, et al. Among authors: may fe. Mol Cancer. 2016 Jan 22;15:8. doi: 10.1186/s12943-015-0482-2. Mol Cancer. 2016. PMID: 26801096 Free PMC article.
TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.
May FE, Westley BR. May FE, et al. Endocr Relat Cancer. 2015 Jun;22(3):465-79. doi: 10.1530/ERC-15-0129. Epub 2015 Apr 21. Endocr Relat Cancer. 2015. PMID: 25900183 Free PMC article.
Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity.
Axon A, May FE, Gaughan LE, Williams FM, Blain PG, Wright MC. Axon A, et al. Among authors: may fe. Toxicology. 2012 Aug 16;298(1-3):40-51. doi: 10.1016/j.tox.2012.04.014. Epub 2012 May 3. Toxicology. 2012. PMID: 22562034
TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease.
Ahmed ARH, Griffiths AB, Tilby MT, Westley BR, May FEB. Ahmed ARH, et al. Am J Pathol. 2012 Mar;180(3):904-916. doi: 10.1016/j.ajpath.2011.11.022. Epub 2012 Feb 16. Am J Pathol. 2012. PMID: 22341453
Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
Jamieson D, Cresti N, Bray J, Sludden J, Griffin MJ, Hawsawi NM, Famie E, Mould EV, Verrill MW, May FE, Boddy AV. Jamieson D, et al. Among authors: may fe. Pharmacogenet Genomics. 2011 Dec;21(12):808-19. doi: 10.1097/FPC.0b013e32834b6918. Pharmacogenet Genomics. 2011. PMID: 21946896
156 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page